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Antibiotic use during pregnancy 
and childhood overweight: A 
population-based nationwide 
cohort study
tine Jess1,2, Camilla S. Morgen3,4, Maria C. Harpsøe5, Thorkild I. A. Sørensen  4,6, 
Teresa A. Ajslev1, Julie C. Antvorskov7 & Kristine H. Allin1,6
Studies in mice suggest that early life represents a critical time window, where antibiotics may exert 
profound and lasting effects on the gut microbiota and metabolism. We aimed to test the hypothesis 
that prenatal antibiotic exposure is associated with increased risk of childhood overweight in a 
population-based cohort study. We linked 43,365 mother-child dyads from a nationwide cohort of 
pregnant women and their offspring to the Danish National Prescription Registry. Linear and logistic 
regression models were used to examine associations between prenatal exposure to antibiotics and BMI 
z-score and overweight (including obesity) at age seven and 11 years. Prenatal antibiotic exposure and 
childhood overweight were both associated with high pre-pregnancy BMI, maternal diabetes, multi-
parity, smoking, low socioeconomic status, high paternal BMI, and short duration of breastfeeding. 
After adjustment for confounders, no associations were observed between prenatal antibiotic exposure 
and odds of overweight at age seven and 11 years. Whereas no association was observed between 
broad-spectrum antibiotics and overweight at age 11 years, exposure to broad-spectrum antibiotics 
was associated with higher odds of overweight at age seven years with an odds ratio of 1.27 (95% CI, 
1.05–1.53) for ampicillin and an odds ratio of 1.56 (95% CI, 1.23–1.97) for amoxicillin. As we did not 
account for underlying infections, the observed associations with early childhood overweight could 
be explained by confounding by indication. In conclusion, our population-based study suggests that 
prenatal exposure to narrow-spectrum antibiotics is not associated with overweight in offspring. 
Exposure to some broad-spectrum antibiotics may increase the odds of overweight in early childhood, 
but the association does not persist in later childhood.
Antibiotics are widely used during pregnancy. Among all pregnant women in Denmark during years 2000–2010, 
approximately one third received antibiotics1. Antibiotics represent one of the most important environmental 
influences on microbial ecology. Specifically, it has been shown that oral antibiotics in pregnancy alter the vaginal 
microbial ecology2. The gut microbiota of children is established during the first few years of life, which repre-
sents a critical time window, where the gut microbiota is especially vulnerable to external influences, including 
antibiotics3. As neonates acquire their microbes from their mother during delivery3, and since several studies 
have suggested that the gut microbiota contributes to metabolic diseases4, it has been hypothesized that exposure 
to antibiotics during pregnancy alters the composition of the founding microbiota of the neonate and thereby 
contributes to development of childhood overweight and obesity3.
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Whereas several studies have examined the association between antibiotics in infancy and overweight5, fewer 
studies have examined whether prenatal exposure is associated with higher odds of childhood overweight, and 
results are conflicting6–10. Three studies reported larger body size among children exposed to antibiotics in utero6–
8. Two included less than 600 participants6,8, and the third study did not control for maternal body mass index 
(BMI)7, which is an important risk factor for childhood overweight11. A fourth study evaluated BMI at age three 
years, and did not find an association between antibiotics and childhood BMI9, whereas a fifth study of children 
born back in 1959–1965 reported no association with obesity at age 4 years, but found that repeated prenatal 
exposure to antibiotics was associated with childhood obesity at age seven years10. Thus, statistically well-powered 
studies with detailed information on antibiotic use as well as on potential confounders are still warranted to deter-
mine the impact of prenatal antibiotic exposure on childhood overweight.
The aim of the present study was to test the hypothesis that prenatal exposure to antibiotics is associated with 
childhood overweight. To address this hypothesis, we linked 43,365 mother-child dyads from a nationwide study 
of pregnant women and their offspring to the Danish National Prescription Registry and examined the odds of 
overweight at age seven and 11 years according to antibiotic exposure in utero, while accounting for a range of 
potential confounders.
Materials and Methods
Study population. The present study is based on the Danish National Birth Cohort, a nationwide ongoing 
study of pregnant women and their offspring. Between 1996 and 2002, women were invited to the cohort at their 
first antenatal visit at the general practitioner. The average response rate was 60%. The pregnant women partic-
ipated in four telephone interviews, scheduled to take place in gestational weeks 12 and 30 as well as six and 18 
months post-partum. Follow-up was undertaken at age seven and 11 years. A total of 100,418 pregnancies were 
enrolled in the cohort12,13. For the present study, we included mother-child dyads, where the birth was a singleton 
term live birth with birth weight >500 g and to ensure independency of the observations, we included only the 
first-born child in case of siblings (n = 81,229). Of these, 43,365 children had information on BMI at age seven 
and/or 11 years of age.
Antibiotic exposure. Information on use of systemic antibiotics – anatomical therapeutic chemical code 
(ATC) J01 – was obtained from the Danish National Prescription Registry which contains information on all pre-
scription drugs dispensed at Danish pharmacies14. Use of antibiotics was quantified as courses with a new course 
defined as a prescription with a minimum of 14 days after the previous prescription of antibiotics. Repeated 
use of the same type of antibiotics within one month was, however, considered as one course. First, second, 
and third trimester was defined as day 0 to 91, day 92 to 189, and day 190 to the date of birth. Type of antibiotic 
was categorized as ever use of (1) beta-lactam antibacterials, penicillins (J01C), (2) sulfonamide and trimethop-
rim (J01E), and (3) macrolides, lincosamides and streptogramins (J01F). Moreover, antibiotics were categorized 
into narrow- and broad-spectrum antibiotics as described in Supplementary Table 1. If mothers received both 
narrow- and broad-spectrum antibiotics they were categorized as having received broad-spectrum antibiotics. 
Broad-spectrum antibiotics were further sub-divided into the categories (1) ampicillin (J01CA01, J01CA02, and 
J01CA06) (2) amoxicillin (J01CA04 and J01CR02), and (3) sulphamethizole (J01EB02). In addition to prenatal 
exposure, we also retrieved information on antibiotic exposure during the first six months of life, which has pre-
viously been shown to associate with childhood overweight5.
Outcome. Outcomes were BMI z-score and overweight at age seven and 11 years. Anthropometrics at age 
seven years were reported by the mother (67%), school doctor, public health nurse, or general practitioner. A later 
evaluation showed that slightly fewer children were categorized as overweight based on self-reported BMI com-
pared to BMI measured by school doctors. However, no systematic differences in the size of the disagreements 
by the child’s size were found15. The mother or father reported information on weight and height at the 11-year 
follow-up. BMI was calculated as body weight divided by the squared height in meters (kg/m2). If the measure-
ments of height and weight were performed at different dates, BMI was calculated only if the two dates were 
separated by <92 days. To address skewness in the BMI distributions, the Lambda-Mu-Sigma (LMS) method 
was used to transform BMI at age seven and 11 years into internal age- and sex-specific z-scores16,17. Overweight 
(including obesity) was defined according to age- and sex-specific criteria defined by the International Obesity 
Task Force18. Thinness grade 2 was defined according to age- and sex-specific criteria defined by the International 
Obesity Task Force19.
Covariates. Information on maternal age at conception, pre-pregnancy BMI, diabetes (gestational diabetes 
or diabetes before pregnancy), gestational weight gain, paternal BMI, smoking during pregnancy, parity, socio-
economic status, and duration of breastfeeding was obtained from the interviews during and after pregnancy11. 
Socioeconomic status was based on the highest level of maternal education and occupation. The measure was 
based on the current or most recent job within six months, or, if the woman was studying, on the educational 
level20. Information on gestational age, child gender, birth mode, and birth weight was obtained from the Danish 
Medical Birth Registry21.
Statistical analyses. Chi-square tests and t-tests were used to test for differences in cohort characteristics 
according to maternal exposure to antibiotics during pregnancy and child overweight at age seven and/or 11 
years. We used linear regression models to examine differences in BMI z-scores between exposed and unex-
posed children and logistic regression models to examine odds ratios (ORs) of overweight. Data were analyzed 
using unadjusted and multivariable-adjusted models. Multivariable-adjustment included maternal age at birth, 
maternal pre-pregnancy BMI, maternal diabetes (yes/no), smoking during pregnancy (0, 0–10, >10 cigarettes 
per day), parity (0, 1+), socio-economic status (low, medium, or high status), gestational age at birth, and child 
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gender. These covariates were included based on their association with the exposure and outcome. We excluded 
mother-child dyads who did not have information on the above-mentioned covariates (n = 5587) implying that 
the same number of individuals was included in unadjusted and adjusted analyses. In a sensitivity analysis, we 
additionally adjusted for gestational weight gain, caesarian section (yes/no), and birth weight (these covariates 
associated with either antibiotics exposure or childhood BMI), duration of any breastfeeding (0.0–19.9; 20.0–31.9; 
32.0–39.9; and 40.0–95.0 weeks; this covariate exerts its effect after the exposure), and paternal BMI (information 
was available only on a subset of the cohort). To examine whether antibiotic exposure during the first six months 
of life confounded the results we additionally adjusted for this. To examine effect modification, we stratified the 
analyses by maternal pre-pregnancy BMI (<25, 25–30, or ≥30 kg/m2), caesarian section, birth weight (<2500, 
2500–3999, or ≥4000 g), and child gender. These variables were chosen based on previous literature demon-
strating effect modification on early-life antibiotics and childhood overweight associations5,7,22,23. All statistical 
analyses were performed using the SAS (SAS Institute) version 9.4.
Ethical approval. Each pregnant woman gave written informed consent at enrolment, also encompassing 
the later follow-up surveys. The establishment of the cohort was approved under ref. no (KF) 01-471/94 by the 
Committee on Biomedical Research Ethics. The Danish Data Protection Agency approved the data collection of 
the cohort, the 7-year follow-up, and the 11-year follow-up.
Results
A total of 43,365 mother-child dyads were included in the study: 40,810 children had information on BMI at age 
seven years and 24,461 had information on BMI at age 11 years (Supplementary Figure 1). Compared to 37,864 
mothers who were not included in the study due to missing information on childhood BMI, the women who were 
included were slightly less likely to receive antibiotics, had slightly lower pre-pregnancy BMI, lower prevalence 
of smoking, higher socioeconomic status, and longer duration of breastfeeding (Supplementary Table 2). At age 
seven years, 10.0% of the children were overweight and at age 11 years, 9.0% of the children were overweight. For 
children with information on overweight at both age seven and 11 years (n = 21,906), 51.8% of the children who 
were overweight at age seven, were also overweight at age 11 years. Among the women included in the present 
study, 24.8% received antibiotics during pregnancy (Supplementary Table 3), and among those who received 
antibiotics, 75.4% received only a single course and 76.1% received penicillins (J01C). Exposure to antibiotics in 
pregnancy was associated with higher pre-pregnancy BMI, higher prevalence of maternal diabetes, multi-parity, 
higher prevalence of smoking, lower socioeconomic status, higher paternal BMI, and shorter duration of breast-
feeding (Table 1). Overweight at age seven or 11 years showed a similar pattern of association and was addition-
ally associated with male gender, higher birth weight, and caesarian section (Table 2). Supplementary Table 4 





Mean ± SD or n (%) Mean ± SD or n (%)
Maternal age at birth, years 43,365 30.2 ± 4.2 30.1 ± 4.3 0.02
Maternal pre-pregnancy BMI, kg/m2 41,057 23.3 ± 3.9 23.8 ± 4.4 <0.001
Maternal diabetes, n (%) 41,871 254 (0.8) 120 (1.2) 0.001
Smoking in pregnancy 41,583 <0.001
     Non-smokers 24,332 (77.8) 7513 (73.0)
     1–10 cigarettes per day 5487 (17.5) 2086 (20.3)
     >10 cigarettes per day 1468 (4.7) 697 (6.8)
Parity ≥ 1, n (%) 41,662 15,292 (48.8) 5686 (55.1) <0.001
Family education/occupational class, n (%) 39,739 <0.001
     Highest level 21,465 (71.7) 6562 (66.9)
     Middle level 7786 (26.0) 2898 (29.6)
     Lowest level 684 (2.3) 344 (3.5)
Gestational age at birth, days 43,365 281.9 ± 8.8 281.9 ± 9.0 0.71
Child gender, girls, n (%) 43,365 15,983 (49.0) 5229 (48.7) 0.53
Weekly gestational weight gain, kg 34,994 0.38 ± 0.1 0.37 ± 0.1 0.03
Paternal BMI, kg/m2 32,999 25.0 ± 3.1 25.2 ± 3.2 <0.001
Birth weight, kg 43,365 3.6 ± 0.5 3.6 ± 0.5 0.27
Cesarean section, n (%) 43,365 4516 (13.9) 1489 (13.9) 0.98
Breastfeeding, n (%) 30,436 <0.001
     0.0–19.9 weeks 5665 (24.7) 2326 (31.2)
     20.0–31.9 weeks 4196 (18.3) 1325 (17.8)
     32.0–39.9 weeks 5421 (23.6) 1588 (21.3)
     40.0–95.0 weeks 7702 (33.5) 2213 (29.7)
Table 1. Characteristics of the study population according to use of antibiotics during pregnancy.
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Antibiotics and childhood overweight. After multivariable-adjustment no association was observed 
between exposure to antibiotics during pregnancy and BMI z-score at age seven years: 0.003 (95% CI, −0.02–
0.03), P = 0.81 or 11 years: 0.004 (95% CI, −0.03–0.03), P = 0.78 (Fig. 1). When analyzing ORs of overweight, we 
observed a comparable pattern. Thus, the multivariable-adjusted OR of overweight at age seven years was 1.07 
(95% CI, 0.98–1.15), P = 0.12 and the OR of overweight at age 11 years was 1.06 (95% CI, 0.95–1.19), P = 0.30 
(Fig. 1). Additional adjustment for gestational weight gain, breastfeeding, caesarian section, birth weight, and 
paternal BMI resulted in similar findings (data not shown).
Robustness. Of the covariates included in the multivariable model, adjustment for pre-pregnancy BMI 
attenuated the ORs most (Supplementary Table 5). Exclusion of children with thinness resulted in simi-
lar ORs of overweight (data not shown). When analyzing odds of obesity, no association was observed after 
multivariable-adjustment (Supplementary Table 6). When stratifying on maternal pre-pregnancy BMI, caesarian 
section, birth weight, and child gender, we observed no association between exposure to antibiotics and over-
weight at age seven or 11 years in any strata after multivariable-adjustment (P for interactions > 0.05) (Table 3).
Dose, time, and type of antibiotics and childhood overweight. After multivariable-adjustment, we 
did not observe any associations between one course, two courses, or more than three courses of antibiotics and 
overweight at age seven or 11 years (Table 4). When studying timing of exposure, only exposure to antibiotics in 
the second trimester was associated with overweight at age seven years (OR, 1.12; 95% CI, 1.01–1.25).
We did not observe an association between exposure to penicillins, sulphonamides and trimethoprim, mac-
rolides, lincosamides, streptogramins, or narrow-spectrum antibiotics and overweight at age seven or 11 years 
(Table 4). However, exposure to broad-spectrum antibiotics was associated with higher odds of overweight at age 
seven years after multivariable adjustment: OR 1.20 (95% CI, 1.07–1.36), P = 0.002 (Table 4). The most widely 
used broad-spectrum antibiotics were sulfamethizole, ampicillin, and amoxicillin. Whereas sulfamethizole was 
not associated with overweight at age seven years, exposure to ampicillin and amoxicillin were associated with 
ORs of overweight of 1.27 (95% CI, 1.05–1.53) and 1.56 (95% CI, 1.23–1.97), respectively. Associations between 
overweight at age seven years and prenatal exposure to broad-spectrum antibiotics, ampicillin, and amoxicillin 
persisted when adjusting for exposure to antibiotics during the first six months of life (Supplementary Table 7). 
No association was observed between the broad-spectrum antibiotics sulfamethizole, ampicillin, or amoxicillin 
and overweight at age 11 years.
n
Overweight at seven or 11 years of age
P value
No Yes
Mean ± SD or n (%) Mean ± SD or n (%)
Maternal age at birth, years 43,365 30.2 ± 4.2 30.1 ± 4.3 0.22
Maternal pre-pregnancy BMI, kg/m2 41,057 23.1 ± 3.8 25.6 ± 5.0 <0.001
Maternal diabetes, n (%) 41,871 306 (0.8) 68 (1.3) <0.001
Smoking in pregnancy 41,583 <0.001
     Non-smokers 28,362 (77.7) 3483 (68.4)
     1–10 cigarettes per day 6384 (17.5) 1189 (23.3)
     >10 cigarettes per day 1743 (4.8) 422 (8.3)
Parity ≥1, n (%) 41,662 18,214 (49.8) 2764 (54.2) <0.001
Family education/occupational class, n (%) 39,739 <0.001
     Highest level 25,086 (71.9) 2941 (60.9)
     Middle level 9000 (25.8) 1684 (34.9)
     Lowest level 823 (2.4) 205 (4.2)
Gestational age at birth, days 43,365 281.9 ± 8.8 282.1 ± 9.0 0.06
Child gender, girls, n (%) 43,365 18,448 (48.5) 2764 (52.1) <0.001
Weekly gestational weight gain, kg 34,994 0.38 ± 0.13 0.38 ± 0.16 0.36
Paternal BMI, kg/m2 32,999 24.9 ± 3.0 26.5 ± 3.6 <0.001
Birth weight, kg 43,365 3.6 ± 0.5 3.8 ± 0.5 <0.001
Cesarean section, n (%) 43,365 5179 (13.6) 826 (15.6) <0.001
Breastfeeding, n (%) 30,436
     0.0–19.9 weeks 6760 (25.3) 1231 (32.9) <0.001
     20.0–31.9 weeks 4892 (18.3) 629 (16.8)
     32.0–39.9 weeks 6239 (23.4) 770 (20.6)
     40.0–95.0 weeks 8807 (33.0) 1108 (29.6)
Table 2. Characteristics of the study population according to child overweight at seven or 11 years of 
age. Overweight (including obesity) was defined according to age- and sex-specific criteria defined by the 
International Obesity Task Force.
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Robustness. When evaluating BMI z-score instead of OR of overweight, broad-spectrum antibiotics and ampi-
cillin were also associated with higher BMI z-score at age seven years (data not shown).
To examine whether selection bias could explain the lack of an association between broad-spectrum antibiot-
ics and overweight at age 11 years, we excluded mother-child dyads that did not have information on BMI at both 
age seven and 11 years, and results remained similar (data not shown). Supplementary Table 8 shows characteris-
tics of mother-child dyads with and without information on BMI at age 11 years.
Discussion
Based on 43,365 mother-child dyads from a nationwide study of pregnant women and their offspring, we found 
that in general, exposure to antibiotics in utero was not associated with higher odds of overweight at age seven or 
11 years after appropriate adjustment for confounders. Exposure to broad-spectrum antibiotics was associated 
with higher odds of overweight at age seven years, but no association was observed with overweight at age 11 
years.
Considering the widespread use of antibiotics in pregnancy1, it is crucial to elucidate any harmful effects of pre-
natal antibiotics on the offspring. As neonates acquire their microbes from their mother during delivery3,24,25, prena-
tal antibiotics may not only disturb the maternal microbiota but also the founding microbiota of the newborn and 
thus the establishment of a healthy and resilient microbiota. In support of this hypothesis, a previous study demon-
strated that intrapartum antibiotics were associated with alterations in the composition and richness of the infant gut 
microbiota26. Several studies have suggested that the gut microbiota may be involved in development of metabolic 
diseases27, and consequently it has been speculated that antibiotics, through their influence on the gut microbiota, 
may contribute to the development of overweight in humans4. Moreover, it has been suggested that early life rep-
resents a critical time window during which antibiotics have an especially profound and lasting impact on the gut 
microbiota and consequently metabolism. Accordingly, a previous study showed that male mice that were exposed 
to low-dose penicillin had increased fat mass and higher hepatic expression of genes involved in adipogenesis in the 
Figure 1. Association between prenatal antibiotics and childhood BMI. (a) BMI z-score among children of 
mothers who received antibiotics vs. children of mothers who did not (b) Odds ratio of childhood overweight 
(including obesity) among children of mothers who received antibiotics vs. children of mothers who did not.
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liver when penicillin was administered to their mothers shortly before birth and during the weaning period com-
pared to administration post weaning28,29. Notably, this study also showed that the growth-promoting phenotype 
could be transferred to germ-free mice via fecal transplants suggesting that the metabolic effects of antibiotics may 
be attributable to effects on the gut microbiota28. Overall, we did not find an association between exposure to antibi-
otics in utero and higher odds of overweight. Ampicillin and amoxicillin were however, both associated with higher 
odds of overweight at age seven years, whereas no association was observed for sulfamethizole; an observation 
which may be attributed to the different antimicrobial spectrum of these antibiotics.
Our finding of no association between prenatal antibiotics exposure in general and childhood overweight is 
in contrast to three studies, which reported higher BMI among children exposed to prenatal antibiotics6–8. These 
three studies were however, limited by either sample size6,8 or lack of control for maternal BMI7. Also, differences 
in prevalence of overweight and pattern of use of antibiotics may explain the conflicting results. Especially, the 
study by Cassidy-Bushrow et al. is not directly comparable to our study as overweight/obesity was evaluated at 
age two years; as the prevalence of overweight/obesity was much higher, and as two times as many women were 
treated with antibiotics in that study6. On the other hand, our results are in accordance with a previous study 
evaluating BMI at age three years9, which also found no association between prenatal exposure to antibiotics and 
childhood overweight. In contrast to our findings of no dose-response relationship between number of antibiotic 
courses and childhood overweight, a study of children born from 1959–1965 reported an association between 
repeated prenatal exposure to antibiotics and childhood obesity at age seven years10. Notably, however, the use of 
broad-spectrum antibiotics in this cohort was twice as high as in the present cohort10.
Compared to the general Danish population, children in the present cohort had a lower prevalence of over-
weight. Data from the Danish National Survey of Diet and Physical Activity (DANSDA) in 2000–2002, 2003–
2004, and 2005–2008 shows that the prevalence estimate of overweight (including obesity) in 4–14-year-old boys 
was 13% in the 2000–2002 examination and 22% in the 2005–2008 examination30. For girls, the correspond-
ing estimates were 18% and 16%. This indicates that the present study, as most observational studies of general 
n
Unadjusted Multivariable-adjusted
OR (95% CI) P value OR (95% CI) P value
Overweight at age seven years
Maternal pre-pregnancy BMI
   Normal weight (<25 kg/m2) 27,238 1.15 (1.04–1.28) 0.007 1.08 (0.97–1.20) 0.17
   Overweight (25–30 kg/m2) 6844 1.12 (0.96–1.29) 0.14 1.08 (0.93–1.25) 0.32
   Obese (≥30 kg/m2) 2548 1.11 (0.91–1.35) 0.31 1.03 (0.84–1.26) 0.78
Caesarean section
   No 31,640 1.21 (1.11–1.31) <0.001 1.08 (0.99–1.17) 0.1
   Yes 4990 1.17 (0.96–1.44) 0.12 0.99 (0.80–1.23) 0.95
Birth weight
   <2500 g 335 1.93 (0.87–4.31) 0.11 1.53 (0.63–3.68) 0.35
   2500–3999 g 27,423 1.17 (1.06–1.28) 0.002 1.04 (0.94–1.14) 0.47
   ≥4000 g 8872 1.24 (1.08–1.42) 0.002 1.11 (0.97–1.28) 0.13
Gender
   Girl 17,804 1.15 (1.03–1.28) 0.01 1.02 (0.92–1.14) 0.69
   Boy 18,826 1.27 (1.14–1.41) <0.001 1.12 (0.99–1.25) 0.06
Overweight at age 11 years
Maternal pre-pregnancy BMI
   Normal weight (<25 kg/m2) 15,897 1.15 (0.98–1.34) 0.08 1.05 (0.90–1.23) 0.52
   Overweight (25–30 kg/m2) 3717 1.10 (0.90–1.33) 0.36 1.06 (0.87–1.29) 0.57
   Obese (≥30 kg/m2) 1321 1.31 (1.01–1.70) 0.04 1.13 (0.86–1.48) 0.38
Cesarean section
   No 18,050 1.26 (1.12–1.41) <0.001 1.07 (0.94–1.20) 0.31
   Yes 2885 1.34 (1.02–1.75) 0.04 1.04 (0.77–1.39) 0.82
Birth weight
   <2500 g 186 0.74 (0.23–2.35) 0.6 0.49 (0.12–1.91) 0.3
   2500–3999 g 15,655 1.22 (1.07–1.40) 0.003 1.03 (0.90–1.18) 0.67
   ≥4000 g 5094 1.36 (1.13–1.63) 0.001 1.15 (0.95–1.40) 0.15
Gender
   Girl 10,472 1.23 (1.05–1.43) 0.009 1.04 (0.89–1.23) 0.6
   Boy 10,463 1.31 (1.13–1.51) <0.001 1.08 (0.92–1.26) 0.35
Table 3. Odds of overweight at age seven and 11 years associated with prenatal antibiotics stratified by maternal 
pre-pregnancy BMI, cesarean section, birth weight, and sex. Overweight (including obesity) was defined 
according to age- and sex-specific criteria defined by the International Obesity Task Force. Multivariable-
adjusted ORs are adjusted for maternal age at birth, maternal pre-pregnancy BMI, maternal diabetes, maternal 
smoking, parity, socio-economic status, gestational age at birth, and child gender.




OR (95% CI) P value OR (95% CI) P value
Overweight at age seven years
No. of antibiotics courses
   0 27,606 1 1
   1 6821 1.18 (1.08–1.28) <0.001 1.08 (0.99–1.18) 0.10
   2 1615 1.34 (1.14–1.56) <0.001 1.13 (0.97–1.33) 0.12
   ≥3 588 1.11 (0.85–1.45)  0.44 0.79 (0.59–1.04) 0.09
Use of antibiotics according to trimester
   No use in pregnancy 27,606 1 1
   First trimester 3295 1.17 (1.04–1.32) 0.008 1.02 (0.90–1.15) 0.76
   Second trimester 3943 1.28 (1.16–1.43) <0.001 1.12 (1.01–1.25) 0.04
   Third trimester 3588 1.15 (1.03–1.29)  0.01 0.99 (0.88–1.11) 0.86
Type of antibiotics
   No antibiotics 27,606 1 1
   Penicillins; beta-lactam antibacterials 6903 1.22 (1.12–1.32) <0.001 1.07 (0.98–1.17) 0.15
   Sulfonamides and trimethoprim 1485 1.06 (0.89–1.27) 0.49 0.95 (0.79–1.13) 0.54
   Macrolides, lincosamides & 
streptogramins 865 1.23 (0.99–1.52) 0.06 1.10 (0.88–1.37) 0.41
Narrow- or broad-spectrum antibiotics
   No antibiotics 27,606 1 1
   Narrow-spectrum antibiotics 5957 1.13 (1.03–1.24) 0.009 0.99 (0.90–1.09) 0.89
   Broad-spectrum antibiotics 3067 1.34 (1.20–1.51) <0.001 1.20 (1.07–1.36) 0.002
Type of broad-spectrum antibiotics
   No antibiotics 27,606 1 1
   Sulfamethizole 1480 1.07 (0.90–1.27) 0.46 0.95 (0.79–1.14) 0.57
   Ampicillin 1094 1.43 (1.20–1.72) <0.001 1.27 (1.05–1.53) 0.01
   Amoxicillin 574 1.76 (1.40–2.22) <0.001 1.56 (1.23–1.97) <0.001
Overweight at age 11 years
No. of antibiotics courses
   0 15,949 1 1
   1 3789 1.20 (1.07–1.36) 0.002 1.05 (0.93–1.19) 0.42
   2 891 1.29 (1.04–1.61) 0.02 0.997 (0.79–1.26) 0.98
   ≥3 306 2.06 (1.51–2.81) <0.001 1.33 (0.95–1.87) 0.1
Use of antibiotics according to trimester
   No use in pregnancy 15,949 1
   First trimester 1790 1.39 (1.19–1.63) <0.001 1.16 (0.98–1.37) 0.08
   Second trimester 2199 1.31 (1.13–1.52) <0.001 1.06 (0.91–1.24) 0.46
   Third trimester 1953 1.31 (1.12–1.53) <0.001 1.06 (0.90–1.25) 0.48
Type of antibiotics
   No antibiotics 15,949 1
   Penicillins; beta-lactam antibacterials 3806 1.29 (1.15–1.45) <0.001 1.06 (0.94–1.20) 0.32
   Sulfonamides and trimethoprim 825 1.13 (0.89–1.43) 0.32 0.94 (0.73–1.20) 0.6
   Macrolides, lincosamides & 
streptogramins 471 1.40 (1.05–1.87) <0.001 1.18 (0.87–1.59) 0.3
Narrow- or broad-spectrum antibiotics
   No antibiotics 15,949 1 1
   Narrow-spectrum antibiotics 3320 1.32 (1.17–1.49) <0.001 1.11 (0.97–1.26) 0.12
   Broad-spectrum antibiotics 1666 1.17 (0.99–1.39) <0.001 0.96 (0.80–1.16) 0.69
Type of broad-spectrum antibiotics
   No antibiotics 15,949 1 1
   Sulfamethizole 822 1.13 (0.89–1.44) 0.31 0.94 (0.73–1.21) 0.65
   Ampicillin 569 1.18 (0.89–1.56) 0.25 0.96 (0.71–1.29) 0.77
   Amoxicillin 314 1.18 (0.81–1.72) 0.38 0.90 (0.60–1.34) 0.6
Table 4. Odds of overweight at age seven and 11 years according to exposure to antibiotics. Overweight 
(including obesity) was defined according to age- and sex-specific criteria defined by the International Obesity 
Task Force. Multivariable-adjusted ORs are adjusted for maternal age at birth, maternal pre-pregnancy BMI, 
maternal diabetes, maternal smoking, parity, socio-economic status, gestational age at birth, and child gender.
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populations, represents a slightly healthier population than the general population, and accordingly, the results 
may not be directly transferable to populations with higher proportions of overweight and obesity.
In our study, exposure to prenatal antibiotics was associated with a range of covariates that also associated 
with higher odds of childhood overweight. Importantly, we observed an association between prenatal antibi-
otics and childhood overweight in un-adjusted analyses, but after multivariable-adjustment only exposure to 
broad-spectrum antibiotics was associated with higher odds of childhood overweight at age seven years. It is 
unclear why we observed an association between prenatal use of broad-spectrum antibiotics and overweight at 
age seven but not at age 11 years. Firstly, as mothers of children who had information on BMI at age 11 years were 
generally healthier than mothers of children who did not have this information, selection bias could influence 
our results; however, results remained similar when analysis was restricted to children who participated in both 
examinations. Secondly, the effect observed at age seven years may attenuate over time and thus no longer be 
present at age 11 years, and thirdly, the association observed at age seven years may simply be a chance finding.
Major strengths of the present study include our thorough adjustment for potential confounders, the appre-
ciable sample size, and the long-term follow-up. Potential limitations must also be acknowledged. First, the most 
important confounding in any pharmaco-epidemiological study is confounding by indication, in this case, con-
founding due to the underlying infections. Indeed, it has been suggested that associations between exposure to 
antibiotics in childhood and childhood overweight actually reflect a relationship between infections (treated 
with antibiotics) and weight gain31. However, we could not retrieve information on indications for antibiotic 
prescriptions precluding assessment of the role of infections. Controlling for confounding by indication usually 
further attenuates any observed associations with medications under study. Thus, had we been able to account 
for underlying infections, some of the associations with antibiotics use observed would likely have been further 
attenuated. Second, although we retrieved information about timing, dosing, and type of antibiotics prescribed 
outside hospitals, we did not have information about antibiotics given during hospitalizations. However, as we 
did observe an association between prenatal antibiotics and childhood overweight before taking confounders into 
account, it seems unlikely that missing information about in-hospital antibiotics should account for our findings 
of no association after multivariable-adjustment. Third, childhood weight and height were self-reported, which 
may influence the precision of our estimates. Lastly, our study results are based on a slightly healthier segment of 
the study population who also had a slightly lower exposure to antibiotics than those not included. Further, the 
regression analyses were based on those who had complete information on all potential confounders. Although 
we cannot exclude selection bias, we assume that the lack of information on single confounders occurs at random. 
Nevertheless, our results may not pertain to populations that are unhealthier than the current study population.
conclusion
Our nationwide study of more than 40,000 mother-child pairs followed prospectively suggests that prena-
tal exposure to narrow-spectrum antibiotics is not associated with overweight in offspring. Exposure to some 
broad-spectrum antibiotics may be associated with higher odds of overweight in early childhood, but not in later 
childhood. As we did not account for underlying infections, the observed association with early childhood over-
weight could be explained by confounding by indication. Generally, our results provide reassuring information 
for clinicians treating pregnant women.
Data Availability
The present study is based on data from the Danish National Birth Cohort and the Danish National Prescription 
Registry. Guidelines to application for access to data from the Danish National Birth Cohort can be found here: 
https://www.dnbc.dk/access-to-dnbc-data. The Danish National Prescription Registry can be accessed through 
application to and approval from the Danish Data Protection Agency and the Danish Health Data Authority 
(https://sundhedsdatastyrelsen.dk/da/forskerservice/ansog-om-data) where the purpose and the feasibility of the 
intended analysis should be accounted for.
References
 1. Broe, A., Pottegard, A., Lamont, R. F., Jorgensen, J. S. & Damkier, P. Increasing use of antibiotics in pregnancy during the period 
2000-2010: prevalence, timing, category, and demographics. BJOG 121, 988–996, https://doi.org/10.1111/1471-0528.12806 (2014).
 2. Stokholm, J. et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect 20, 629–635, 
https://doi.org/10.1111/1469-0691.12411 (2014).
 3. Cox, L. M. & Blaser, M. J. Antibiotics in early life and obesity. Nat Rev Endocrinol 11, 182–190, https://doi.org/10.1038/
nrendo.2014.210 (2015).
 4. Mikkelsen, K. H., Allin, K. H. & Knop, F. K. Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: 
a review of the literature. Diabetes Obes Metab 18, 444–453, https://doi.org/10.1111/dom.12637 (2016).
 5. Rasmussen, S. H. et al. Antibiotic exposure in early life and childhood overweight and obesity: A systematic review and meta-
analysis. Diabetes Obes Metab, https://doi.org/10.1111/dom.13230 (2018).
 6. Cassidy-Bushrow, A. E. et al. Prenatal antimicrobial use and early-childhood body mass index. International Journal Of Obesity 42, 
1, https://doi.org/10.1038/ijo.2017.205 (2017).
 7. Mor, A. et al. Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study. 
Int J Obes (Lond) 39, 1450–1455, https://doi.org/10.1038/ijo.2015.129 (2015).
 8. Mueller, N. T. et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 39, 665–670, 
https://doi.org/10.1038/ijo.2014.180 (2015).
 9. Poulsen, M. N. et al. Associations of prenatal and childhood antibiotic use with child body mass index at age 3 years. Obesity (Silver 
Spring) 25, 438–444, https://doi.org/10.1002/oby.21719 (2017).
 10. Wang, B. et al. Prenatal Exposure to Antibiotics and Risk of Childhood Obesity in a Multi-Center Cohort Study. Am J Epidemiol, 
https://doi.org/10.1093/aje/kwy122 (2018).
 11. Morgen, C. S. et al. Prenatal risk factors influencing childhood BMI and overweight independent of birth weight and infancy BMI: 
a path analysis within the Danish National Birth Cohort. Int J Obes (Lond), https://doi.org/10.1038/ijo.2017.217 (2017).
9Scientific RepoRtS |         (2019) 9:11528  | https://doi.org/10.1038/s41598-019-48065-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 12. Nybo Andersen, A. M. & Olsen, J. Do interviewers’ health beliefs and habits modify responses to sensitive questions? A study using 
data Collected from pregnant women by means of computer-assisted telephone interviews. Am J Epidemiol 155, 95–100 (2002).
 13. Olsen, J. et al. The Danish National Birth Cohort–its background, structure and aim. Scand J Public Health 29, 300–307 (2001).
 14. Kildemoes, H. W., Sorensen, H. T. & Hallas, J. The Danish National Prescription Registry. Scand J Public Health 39, 38–41, https://
doi.org/10.1177/1403494810394717 (2011).
 15. Andersen, C. Validation of the anthropometric data in the 7-year follow-up. Internet: http://www.ssi.dk/English/RandD/Research%20
areas/Epidemiology/DNBC/Publications%20on%20Background%20and%20Methods/Validation%20of%20height%20weight%20
and%20waist%20circumference.aspx.
 16. Cole, T. J. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44, 45–60 (1990).
 17. Cole, T. J. & Green, P. J. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11, 1305–1319 (1992).
 18. Cole, T. J., Bellizzi, M. C., Flegal, K. M. & Dietz, W. H. Establishing a standard definition for child overweight and obesity worldwide: 
international survey. BMJ 320, 1240–1243 (2000).
 19. Cole, T. J., Flegal, K. M., Nicholls, D. & Jackson, A. A. Body mass index cut offs to define thinness in children and adolescents: 
international survey. BMJ 335, 194, https://doi.org/10.1136/bmj.39238.399444.55 (2007).
 20. Nohr, E. A. et al. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 106, 
250–259, https://doi.org/10.1097/01.AOG.0000172422.81496.57 (2005).
 21. Knudsen, L. B. & Olsen, J. The Danish Medical Birth Registry. Dan Med Bull 45, 320–323 (1998).
 22. Ajslev, T. A., Andersen, C. S., Gamborg, M., Sorensen, T. I. & Jess, T. Childhood overweight after establishment of the gut microbiota: 
the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 35, 522–529, https://doi.
org/10.1038/ijo.2011.27 (2011).
 23. Stokholm, J. et al. Cesarean section changes neonatal gut colonization. J Allergy Clin Immunol 138, 881–889 e882, https://doi.
org/10.1016/j.jaci.2016.01.028 (2016).
 24. Backhed, F. et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe 17, 852, 
https://doi.org/10.1016/j.chom.2015.05.012 (2015).
 25. Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and 
stability. Sci Transl Med 8, 343ra381, https://doi.org/10.1126/scitranslmed.aad0917 (2016).
 26. Azad, M. B. et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first 
year of life: a prospective cohort study. BJOG 123, 983–993, https://doi.org/10.1111/1471-0528.13601 (2016).
 27. Allin, K. H., Nielsen, T. & Pedersen, O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur 
J Endocrinol 172, R167–177, https://doi.org/10.1530/EJE-14-0874 (2015).
 28. Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 
158, 705–721, https://doi.org/10.1016/j.cell.2014.05.052 (2014).
 29. Jess, T. Microbiota, antibiotics, and obesity. N Engl J Med 371, 2526–2528, https://doi.org/10.1056/NEJMcibr1409799 (2014).
 30. Matthiessen, J. et al. Trends in overweight and obesity in Danish children and adolescents: 2000–2008–exploring changes according 
to parental education. Scand J Public Health 42, 385–392, https://doi.org/10.1177/1403494813520356 (2014).
 31. Li, D.-K., Chen, H., Ferber, J. & Odouli, R. Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth 
cohort study. The Lancet Diabetes & Endocrinology 5, 18–25, https://doi.org/10.1016/S2213-8587(16)30281-9 (2017).
Acknowledgements
We are indebted to the participants and staff of the Danish National Birth Cohort for their important 
contributions. The work was supported by grant number NNF15OC0017740 from the Novo Nordisk Foundation 
and grant number DFF – 6110-00075 from the Danish Council for Independent Research|Medical Sciences. The 
funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation 
of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for 
publication.
Author contributions
T.A.A., T.J. and K.H.A. conceived and designed the study. C.S.M. and K.H.A. analyzed the data. T.J., C.S.M., 
M.C.H., T.I.A.S., T.A.A., J.C.A. and K.H.A. were all involved in the data interpretation. K.H.A. drafted the 
manuscript. T.J., C.S.M., M.C.H., T.I.A.S., T.A.A., J.C.A. and K.H.A. all critically revised the manuscript for 
important intellectual content and approved the final version of the manuscript. T.J. and K.H.A. had full access to 
all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-48065-9.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
